Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News BridgeBio Pharma secures $299m in funding to accelerate genetic disease drug development BridgeBio Pharma, a leading clinical-stage biopharma company specialising in treatments for genetic diseases, has raised $299.2 million in… bypharmanewsdailyFebruary 10, 2019